Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer

Những quyển sách tương tự

• Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
  Bằng: Koji Takada, et al.
  Được phát hành: (2018-04-01)
• Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer
  Bằng: Kashiwagi, Shinichiro, et al.
  Được phát hành: (2017)
• Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
  Bằng: Goto, Wataru, et al.
  Được phát hành: (2017)
• Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression
  Bằng: Asano, Yuka, et al.
  Được phát hành: (2018)
• Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy
  Bằng: Goto, Wataru, et al.
  Được phát hành: (2018)